Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Mar 2;24(1):50.
doi: 10.1007/s10238-023-01281-0.

RUNX transcription factors: biological functions and implications in cancer

Affiliations
Review

RUNX transcription factors: biological functions and implications in cancer

Xinyi Chen et al. Clin Exp Med. .

Abstract

Runt-related transcription factors (RUNX) are a family of transcription factors that are essential for normal and malignant hematopoietic processes. Their most widely recognized role in malignancy is to promote the occurrence and development of acute myeloid leukemia. However, it is worth noting that during the last decade, studies of RUNX proteins in solid tumors have made considerable progress, suggesting that these proteins are directly involved in different stages of tumor development, including tumor initiation, progression, and invasion. RUNX proteins also play a role in tumor angiogenesis, the maintenance of tumor cell stemness, and resistance to antitumor drugs. These findings have led to the consideration of RUNX as a tumor biomarker. All RUNX proteins are involved in the occurrence and development of solid tumors, but the role of each RUNX protein in different tumors and the major signaling pathways involved are complicated by tumor heterogeneity and the interacting tumor microenvironment. Understanding how the dysregulation of RUNX in tumors affects normal biological processes is important to elucidate the molecular mechanisms by which RUNX affects malignant tumors.

Keywords: Angiogenesis; Drug resistance; RUNX family; Signaling pathways; Tumor cell stemness; Tumor microenvironment.

PubMed Disclaimer

Conflict of interest statement

The authors have no relevant financial or non-financial interests to disclose.

Figures

Fig. 1
Fig. 1
Pan-cancer assessment of RUNX family members' expression in comparison with normal tissues, sourced from the TCGA and GTEx databases. The violin plots consistently illustrate differences between normal tissues (depicted in orange) and tumor samples (depicted in gray). A RUNX1, B RUNX2, and C RUNX3 expression variations among different malignancies. *P < 0.05, **P < 0.01, ***P < 0.001
Fig. 2
Fig. 2
Prognostic implications of RUNX family gene expressions in various cancers. A RUNX1, B RUNX2, and C RUNX3: Kaplan–Meier curves depict the correlation of high RUNX expression (in red) with overall survival (OS). Data sourced from the Kaplan–Meier plotter database. P-values and hazard ratios (HR) were calculated using the logrank test to indicate the statistical significance of the survival outcomes
Fig. 3
Fig. 3
Comprehensive roles of RUNX family genes in oncogenesis. The diagram explicitly highlights the pivotal functions of RUNX genes across diverse cancer hallmarks, emphasizing the RUNX-associated effects on cellular proliferation and invasion, metastatic dissemination, angiogenesis, chemoresistance, and maintenance and self-renewal of cancer stem cells

Similar articles

Cited by

References

    1. Chuang LS, Ito K, Ito Y. RUNX family: regulation and diversification of roles through interacting proteins. Int J Cancer. 2013;132(6):1260–71. - PubMed
    1. Bae SC. Tour d’Horizon of recent advances in RUNX family gene research. Mol Cells. 2020;43(2):97–8. - PMC - PubMed
    1. Durst KL, Hiebert SW. Role of RUNX family members in transcriptional repression and gene silencing. Oncogene. 2004;23(24):4220–4. - PubMed
    1. Otalora-Otalora BA, Henriquez B, Lopez-Kleine L, Rojas A. RUNX family: oncogenes or tumor suppressors (review). Oncol Rep. 2019;42(1):3–19. - PMC - PubMed
    1. Martinez-Soria N, McKenzie L, Draper J, Ptasinska A, Issa H, Potluri S, Blair HJ, Pickin A, Isa A, Chin PS, Tirtakusuma R, Coleman D, Nakjang S, Assi S, Forster V, Reza M, Law E, Berry P, Mueller D, Osborne C, Elder A, Bomken SN, Pal D, Allan JM, Veal GJ, Cockerill PN, Wichmann C, Vormoor J, Lacaud G, Bonifer C, Heidenreich O. The oncogenic transcription factor RUNX1/ETO corrupts cell cycle regulation to drive leukemic transformation. Cancer Cell. 2018;34(4):626–42. - PMC - PubMed

MeSH terms

Substances